logo image
search icon
DNA Nanotechnology Market

DNA Nanotechnology Market Size, Share & Trends Analysis Report By Type (Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Template Assembly), Dynamic DNA Nanotechnology (Nanomechanical Devices, Strand Displacement Cascades)), By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), By Region, And By Segment Forecasts, 2024-2031

Report ID : 2402 | Published : 2024-03-21 | Pages: 180 | Format: PDF/EXCEL

DNA Nanotechnology Market Size is valued at USD 4.34 Bn in 2023 and is predicted to reach USD 24.29 Bn by the year 2031 at a 24.67% CAGR during the forecast period for 2024-2031.

DNA Nanotechnology Market info

DNA nanotechnology is a potent tool in computing, electronics, medicine, and materials science because of its unique programmability, accuracy, and biocompatibility. The field's ongoing study and development are bringing up new opportunities to use life's molecular machinery to tackle difficult issues in science and engineering. This technique takes advantage of DNA's unique base-pairing characteristics to construct intricate molecular shapes and patterns. Rising R&D spending, expanding medical and biotech applications, and improved nanofabrication methods are the main forces propelling the DNA nanotechnology industry worldwide. Solutions based on DNA nanotechnology are also seeing increased adoption due to the growing demand for tailored drug delivery systems and personalized treatment. Another factor fueling the global rise of the DNA nanotechnology market is the cooperation between research organizations, academic institutions, and industry players. The expansion of the DNA nanotechnology market is being propelled by the expansion of its potential applications in domains including quantum information processing and nanotechnology circuitry, made possible by its combination with photonics and microelectronics.

However, the market growth is hampered by the high cost of developing and commercializing DNA nanotechnology products, worries about the scaling and replication of manufacturing procedures, and regulatory obstacles related to the security and effectiveness of DNA-based products are some of the challenges that restrict the market growth. In addition, COVID-19 increased the pace of scientific investigation, especially in diagnosis, treatment, and vaccine creation. Innovative vaccine delivery techniques and quick and sensitive diagnostic tests for SARS-CoV-2 detection have been made possible using DNA nanotechnology.

Competitive Landscape

Some Major Key Players In The DNA Nanotechnology Market:

  • Genisphere LLC
  • INOVIO Pharmaceuticals
  • Tilibit nanosystems
  • Aummune Therapeutics Ltd
  • Nanovery
  • Esya Labs
  • Nomic
  • Torus Biosystems
  • Parabon NanoLabs, Inc.
  • NanoApps Medical Inc.
  • Fox BIOSYSTEMS
  • Nanion Technologies GmbH
  • Mehr Mabna Darou, Inc.
  • Nanowerk
  • NuProbe
  • Twist Bioscience Corporation
  • NanoInk Inc.
  • Oxford Nanopore Technologies Ltd.
  • Illumina Inc.
  • Agilent Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Bruker Corporation
  • New England Biolabs Inc.
  • Other Prominent Players

Market Segmentation:

The DNA nanotechnology market is segmented based on type, application, and end user. Based on type, the market is segmented into structural DNA nanotechnology and dynamic DNA nanotechnology. By application, the market is segmented into targeted drug delivery, smart pills, nanolithography, and others. By end user, the market is segmented into academic & research institutions, biotechnology & pharmaceutical companies, and others.

Based On The Type, The Structural DNA Nanotechnology Segment Is Accounted As A Major Contributor To The DNA Nanotechnology Market. 

The structural DNA nanotechnology DNA nanotechnology market is expected to hold a large global market share in 2022. Owing to its novel method for fabricating accurately and being amenable to programming nanostructures. Many fields, including nano-electronic device creation, targeted medication delivery, and medical diagnostics, can benefit from this technology's capacity to create intricate molecular structures and patterns. This technology's acceptance and market expansion is propelled by its revolutionary potential in several sectors.

Biotechnology & Pharmaceutical Companies Segment To Witness Growth At A Rapid Rate.

Biotechnology and pharmaceutical companies are growing rapidly due to their growing spending on research and development, an uptick in interest in individualized healthcare, and a pressing need for novel medication delivery methods and treatment strategies. Because of these reasons, DNA nanotechnology is being used to create better, more specific medicines, growing this segment.

In The Region, The North American DNA Nanotechnology Market Holds A Significant Revenue Share.

The North American DNA nanotechnology market is expected to register the maximum market revenue share in the near future. It can be attributed to the fact that the nation is home to a sizable biotechnology industry and several prominent business figures. Government subsidies and initiatives and a sufficient financial environment have fostered research and development endeavours. In addition, Asia Pacific is predicted to grow rapidly in the global DNA nanotechnology market because rising healthcare spending, a thriving biotech industry, and a flood of capital from outside investors in key Asian markets are all factors fueling the boom. Additionally, a positive growth driver is the increasing attention of global businesses toward the expanding markets of the Asia Pacific region.

Recent Developments:

  • In January 2024, Danaher Corporation announced the acquisition of Aldevron. Aldevron produces high-quality plasmid DNA, mRNA, and proteins for its customers in the biotechnology and pharmaceutical industries, who use them in research, clinical trials, and commercial applications.
  • In Jan 2023, Agilent Technologies Inc. acquired Avida Biomed, a young startup in the field of life sciences. Avida Biomed has created advanced target enrichment procedures with distinctive features that are particularly useful for clinical researchers that employ next-generation sequencing (NGS) methods to investigate cancer. The acquisition enhanced Agilent's already dominant SureSelect portfolio and further supported Agilent's plan to enter the rapidly growing clinical research and diagnostics sectors.  

DNA Nanotechnology Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 4.34 Bn

Revenue Forecast In 2031

USD 24.29 Bn

Growth Rate CAGR

CAGR of 24.67% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Type, Application, And End-User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea

Competitive Landscape

NuProbe, GATTAQUANT GMBH, Genisphere LLC, INOVIO Pharmaceuticals., Tilibit nanosystems, Aummune Therapeutics Ltd., Nanovery, Esya Labs, Nomic, Torus Biosystems, Parabon NanoLabs, Inc., NanoApps Medical Inc., Fox BIOSYSTEMS, Nanion Technologies GmbH, Mehr Mabna Darou, Inc., Nanowerk, Twist Bioscience Corporation, NanoInk Inc., Oxford Nanopore Technologies Ltd., Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Bruker Corporation, New England Biolabs Inc., Other Market Players

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global DNA Nanotechnology Market Snapshot

Chapter 4. Global DNA Nanotechnology Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis

5.1. by Type & Market Share, 2019 & 2031

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type;

5.2.1. Structural DNA Nanotechnology

5.2.1.1. Extended Lattices

5.2.1.2. Discrete Structures

5.2.1.3. Template Assembly

5.2.2. Dynamic DNA Nanotechnology

5.2.2.1. Nanomechanical Devices

5.2.2.2. Strand Displacement Cascades

Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis

6.1. by Application & Market Share, 2019 & 2031

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application;

6.2.1. Targeted Drug Delivery

6.2.2. Smart Pills

6.2.3. Nanolithography

6.2.4. Others

Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis

7.1. by End-user & Market Share, 2019 & 2031

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user;

7.2.1. Biotechnology & Pharmaceutical Companies

7.2.2. Academic & Research Institutions

7.2.3. Others

Chapter 8. DNA Nanotechnology Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031

8.1.2. North America DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.1.3. North America DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031

8.1.4. North America DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

8.2. Europe

8.2.1. Europe DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031

8.2.2. Europe DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.2.3. Europe DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031

8.2.4. Europe DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

8.3. Asia Pacific

8.3.1. Asia Pacific DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031

8.3.2. Asia Pacific DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.3.3. Asia-Pacific DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031

8.3.4. Asia Pacific DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

8.4. Latin America

8.4.1. Latin America DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031

8.4.2. Latin America DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.4.3. Latin America DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031

8.4.4. Latin America DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031

8.5.2. Middle East & Africa DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.5.3. Middle East & Africa DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031

8.5.4. Middle East & Africa DNA Nanotechnology Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Genisphere LLC

9.2.2. INOVIO Pharmaceuticals

9.2.3. Tilibit nanosystems

9.2.4. Aummune Therapeutics Ltd

9.2.5. Nanovery

9.2.6. Esya Labs

9.2.7. Nomic

9.2.8. Torus Biosystems

9.2.9. Parabon NanoLabs, Inc.

9.2.10. NanoApps Medical Inc.

9.2.11. Fox BIOSYSTEMS

9.2.12. Nanion Technologies GmbH

9.2.13. Mehr Mabna Darou, Inc.

9.2.14. Nanowerk

9.2.15. NuProbe

9.2.16. Twist Bioscience Corporation

9.2.17. NanoInk Inc.

9.2.18. Oxford Nanopore Technologies Ltd.

9.2.19. Illumina Inc.

9.2.20. Agilent Technologies Inc.

9.2.21. Thermo Fisher Scientific Inc.

9.2.22. Bio-Rad Laboratories Inc.

9.2.23. Danaher Corporation

9.2.24. Bruker Corporation

9.2.25. New England Biolabs Inc.

9.2.26. Other Prominent Players

Segmentation of DNA Nanotechnology Market-

DNA Nanotechnology Market By Type-

  • Structural DNA Nanotechnology
    • Extended Lattices
    • Discrete Structures
    • Template Assembly
  • Dynamic DNA Nanotechnology
    • Nanomechanical Devices
    • Strand Displacement Cascades

DNA Nanotechnology Market seg

DNA Nanotechnology Market By Application-

  • Targeted Drug Delivery
  • Smart Pills
  • Nanolithography
  • Others

DNA Nanotechnology Market By End User-

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutions
  • Others

DNA Nanotechnology Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the DNA Nanotechnology Market Size?

DNA Nanotechnology Market is expected to grow at a 24.67% CAGR during the forecast period for 2024-2031.

NanoInk Inc., Oxford Nanopore Technologies Ltd., Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., D

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Biotechnology

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach